Abstract B012: Results From the Phase 1 Dose Escalation and Dose Expansion Study of Azenosertib, a WEE1 Inhibitor, in Patients With Advanced Solid TumorsFunda Meric-Bernstam, Anthony W. Tolcher, Deborah B. Doroshow et al.|Molecular Cancer Therapeutics|2025Cited by 0